Michigan Medicine and Cleveland Clinic researchers have found that patients with irritable bowel syndrome were more likely to ...
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
CSL (ASX:CSL) has reported a net profit after tax of $2.01 billion for the six months to the ned of December 2024, up 7 per ...
The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...
Piper Sandler analyst Jason Bednar downgraded Koru Medical (KRMD) to Neutral from Overweight with an unchanged price target of $4.50. The ...
Australia's biotech giant CSL Ltd reported a 5% rise in its first-half profit on Tuesday, boosted by growth in its core immunoglobulin business across geographies, while low U.S. immunisation rates ...
CSL’s vaccine division is suffering as Americans turn away from flu vaccinations, with a “very severe” influenza season ...
Health insurers process more than five billion payment claims annually, federal figures show. About 850 million are denied, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results